14.大阪府済生会中津病院 糖尿病内分泌内科 
へもどる
へもどるへもどる
米国糖尿病学会(1998Texas) 日本糖尿病学会（2001京都） 近畿糖尿病の自己管理(2001
大阪)
2004 邦 文 出
版
英 文原著(2003) 68.Haruo Nishimura, Mitsuyo Shintani, Kouji Maeda Possile Exrtra-pancreaic Effects of Nateglinide on Glucose Metabolism in Type 2 Diabetes Mellitus Diabetes, 52(S1), A461,,2003
邦 文 2003 64.西村治男、新谷光世、前田康司 生活習慣の改善 「糖尿病の有名人は？」 肥満と糖尿病 2(1), 94-95, 2003
65.西村治男、新谷光世、梶本智奈美 糖尿病の運動療法--水中運動療法の意義と利点（運動制限がある患者の有効な運動療法について） DIabetes Frontier 14(1), 53-57, 2003
66.西村治男、新谷光世、前田康司 インスリン注入器の選び方 肥満と糖尿病 2(2),68-71, 2003
67.西村治男、新谷光世、小川佳宏、中尾一和 レ プチンとMultiple Risk Factor症候群 Heart View, 7(5), 597-602,2003
68.西村治男、新谷光世,小川佳宏、中尾一和 「内 臓脂肪と皮下脂肪」 ホルモンと臨床51(4), 343-347, 2003
69.新谷光世、岡崎順子、前田康司、西村治男 「高度肥満 症」 日本臨床61(6),727-732,2003
70.西村治男、岡崎順子、新谷光世、前田康司 「肥満教室の効果と問題点」 日本臨床 61 (6),716-721,2003
71.新谷光世、清田尚臣、前田康司、西村治男「ジピリダモールが奏効した成人型低リン血症性骨軟化症の1例」 ホ ルモンと臨床 51(興味ある症例 第2集）, 189-192, 2003
72.西村治男、新谷光世、小川佳宏、中尾一和 アディポネクチンの治療応用 内分泌・糖尿病科 16(6),548-553, 2003
73.西村治男 ARKRAY information for Diabetes Educator Vol.1, 20, 2003 糖尿病と共に・・・1「藤原道長」
74.西村治男 ARKRAY information for Diabetes Educator Vol.2, 20, 2003 糖尿病と共に・・・2「北原白秋」
75.新谷光世、西村治男、小川佳宏、中尾一和 レプチンの抗肥満・抗インスリン抵抗性のメカニズム 内分泌・糖 尿病科 16(5),476-481, 2003
76.西村治男 ARKRAY information for Diabetes Educator Vol.3, 20, 2003 糖尿病と共に・・・3「坪井栄」
77.新谷光世、西村治男、小川佳宏 これからの臨床医に必要な分子生物学 〜血管の形成と障害〜「レプチンと肥満」 Heart View 7(12),276-279, 2003
78.梶本智奈美、田中孝姫、阪倉あ や、大谷純子、水野由佳子、奥田緑、新谷光世、前田康司、西村治男 効果的な有酸素 運動とはー非肥満症における水中トレッドミルとエルゴメーターの比較 肥満研究 (日本肥満学会学会誌) 9 (3), 317-322, 2003
学会研究会 (2003)
116.糖尿病治療最前線 (2003.2.5 大阪）糖尿病治療最前線 西村治男
117.第25回糖尿病治療研究会 (2003.2.8 京都） -イスリン製剤・注入器の変遷- 西村治男
118.大阪市北区病診連携・糖尿病の会 （2003.3.13 大阪） インスリン治療の過去と未来 西村治男、新谷光世、前田康司
119.大阪市北区病診連携・糖尿病の会 （2003.3.13 大阪） すべての大血管障害を合併した典型的な末期糖尿病の一例--大血管障害の恐ろしさを考える-- 新谷光世、前田康司、西村治男
120.大阪市北区病診連携・糖尿病の会 （2003.3.13 大阪） 中間型インスリン製剤の点滴静注により低血糖を来した一例--低血糖の鑑別・治療、高齢者糖尿病について---- 辰巳新水、新谷光世、前田康司、西村治男
121.大阪市北区病診連携・糖尿病の会 （2003.3.13 大阪） アルコール多飲を契機に急激に発症した糖尿病性ケトアシドーシスの一例---ケトアシドーシスの鑑別と治療について--- 吉田有希子、新谷光世、前田康司、西村治男
122.大塚食品研究会 「健康父さんと生活習慣病」(2003.4.11 滋賀) 西村治男
123.大阪糖尿病勉強会 「糖尿病の検査--基礎と 臨床--」 (2003.4.16 大阪) 西村治男
124.大阪高脂血症勉強会「高脂血症の日常診療にお けるポイント」(2003.4.22 大阪) 西村治男
125.大阪中津済生会病院集談会 (2003.4.25 大阪） 肥満の成因・治療のトピックス 新谷光世
126.第７６回日本内分泌学会総会 (2003.5.9 -11 横浜） 糖尿病患者の動脈硬化とPWVの測定意義
新谷光世、山平正浩*、吉田壽幸*、前田康司、西村治男 (*検査技術科）
127.大阪西淀川医師会講演会 「甲状腺の日常診療 のポイント」(2003.5.20 大阪)
128.日本糖尿病学会総会 (2003.5.22 -24 富山） 糖尿病患者におけるPWVの測定意義について 山平正 浩*、吉田壽幸*、前田康司、新谷光世、西村治男 (*検査技術科）
129.ADA (American Diabetes Association: Scentific Session) （2003.6.14-17 New Orliens in the U.S.A) Possile Exrtra-pancreaic Effects of Nateglinide on Glucose Metabolism in Type 2 Diabetes MellitusHaruo Nishimura, Mitsuyo Shintani, Kouji Maeda
130.第8回淀川糖尿病を語る会 「糖尿病療養指導士のあり方を考える」(2003.6.26 大阪) 西村治男、新谷光世、前田康司
131.第8回淀川糖尿病を語る会 「検査技師としての取り組み」(2003.6.26 大阪) 山平正浩、新谷光世、前田康司、西村治男
132.第8回淀川糖尿病を語る会 「理学療法士としての取り組み」(2003.6.26 大阪) 阪倉あや、新谷光 世、前田康司、西村治男
133.平成15年度 福井ライフ・アカデミー「現代的課題講座 生命・健康.6」 〜隠れ肥満、解 消術！生活習慣病の話し〜(2003.7.6 福井) 西村治男
134.第3回糖尿病教育資源共有機構年次学術集会 ワークショップ「患者の期待する糖尿病におけるIT利用法とは」(2003.8.3 京都) 司会 西村治男
135.第10回全国済生会糖尿病セミナー2003 21世紀の糖尿病診療-その現状と将来- (2003.7.26 福井) 分科会2司会 西村治男
136.第10回全国済生会糖尿病セミナー2003 糖尿病療養指導士としての検査技師の取組み (2003.7.26 福井) 中 平純子 長尾美和子 山平正浩 安田久仁恵 西村治男
137.大阪内科懇話会（2003.8.31 大阪） 1型糖尿病と橋本病をともなったKennedy病の1例 中野厚生、青谷大介、新谷光世、前 田康司、西村治男
138.第9回よどがわ糖尿病を語る会 (2003.10.23 大阪)「SU剤の二次無 効について」新谷光世、鎌田千晶、中野厚生、青谷大介、前田康司、西村治男
139.第9回よどがわ糖尿病を語る会 (2003.10.23 大阪)「糖尿病治療実施 における疑問点」西村治男
140.糖尿病勉強会 「糖尿病診療における”落とし穴”」(2003.10.23 大阪) 西村治男
141. 第40回日本糖尿病学会近地方会 1型糖尿病と橋本病を合併した Kennedy-Alter-Sung病の一例 中野厚生、 前田康司、青谷大介、新谷光世、西村治男 (2003.11.8 神戸)
142. 第40回日本糖尿病学会近地方会 コントロール不良の糖尿病に橋および橋外型髄鞘崩壊症をきたした一例 新谷光世、中野厚生、 青谷大介、前田康司、西村治男 (2003.11.8 神戸)
143. 大阪糖尿病勉強会 (2003.11.１９ 大阪) 糖尿病診療のピットフォール 西村治男
144. 大阪府済生会中津病院北１５階糖尿病療養指導士勉強会 (2003.1１．２６ 大阪) 糖尿病診療の「落とし穴」 西村治男
145. 第８回京都成人病科学カンファランス (2003.11.29 京都) nephrolithiasisを伴ったCushing 症候群の一例〜生活習慣病と内分泌疾患〜鎌田千晶、青谷大介、中野厚生、新谷光世、前田康司、西村治男
146.大阪府済生会中津病院 糖尿病患者会 こわいぞ糖尿病の合併症 前田康司 (2003.11.29 大阪)
147.大阪市医師会病診連携勉強会 (2003.12.06 大阪) 喘息と糖尿病 前田康司、青谷大介、中野厚生、新谷光世、西村治男
148.大阪市医師会病診連携勉強会 Basedow病を伴ったPapillary Carcinomaの一例 西村治男、前田康司、谷大介、中野厚生、新谷光世 (2003.12.06 大阪)
英文原著 (since 1986)
1. Yoshimasa Y, Okamoto M, Yamada K, Nishimura H, Sakamoto Y, Kuzuya H, Imura H. Purification of Insulin Receptor from Human Placental Membranes. Jpn Arch Int Med 33: 337-347, 19862. Yoshimasa Y, Kakehi T, Yamada K, Nishimura H, Ida T, Takeda J, Kosaki A, Kato Y, Seino Y, Kuzuya H, Imura H, Kikuchi K, Seino S, Bell GI. Insulin Receptors and Its Gene in Pathologic State. J Japan Diab Soc 29: 1179-1180, 1986
3. Kakehi T, Kuzuya H, Yoshimasa Y, Yamada K, Okamoto M, Nishimura H, Imura H. Binding and tyrosine kinase activities of the insulin receptor on Epstein-Barr virus transformed lymphocytes from patients with Werner's syndrome. J Gerontol 43: 40-45, 19884. Tsukahara H, Kikuchi K, Kuzuya H, Ito E, Oda Y, Kosaki A, Kakehi T, Nishimura H, Yamada K, Yoshimasa Y, Imura H. Insulin resistance in a boy with congenital generalized lipodystrophy. Pediatr Res 24(6): 668-672,1988
5. Kosaki A, Kuzuya H, Yoshimasa Y, Yamada K, Okamoto M, Nishimura H, Kakehi T, Takeda J, Seino Y, Imura H. Regulation of glucose-transporter gene expression by insulin in cultured human fibroblasts. Diabetes 37(11): 1583-1586, 1988
6.Nishimura H, Kuzuya H, Okamoto M, Yoshimasa Y, Yamada K, Ida T, Kakehi T, Imura H. Change of insulin action with aging in conscious rats determined by euglycemic clamp. Am J Physiol 254: E92-E98, 1988
7. Kakehi T, Hisatomi A, Kuzuya H, Yoshimasa Y, Okamoto M, Yamada K, Nishimura H, Kosaki A, Nawata H, Umeda F, Imura H. Defective processing of insulin-receptor precursor in cultured lymphocytes from a patient with extreme insulin resistance. J Clin Invest 81: 2020-2022, 1988
8.Nishimura H, Kuzuya H, Okamoto M, Yamada K, Kosaki A, Kakehi T, Inoue G, Kono S, Imura H. Postreceptor defect in insulin action in streptozotocin-induced diabetic rats. Am J Physiol 256: E624-E630, 1989
9. Kono S, Kuzuya H, Okamoto M, Nishimura H, Kosaki A, Kakehi T, Okamoto M, Inoue G, Maeda I, Imura H. Changes in insulin receptor kinase with aging in rat skeletal muscle and liver. Am J Physiol 259: E27-E35, 199010. Simpson IA, Cushman SW, Egan JJ, Habberfield AD, Londos C, Nishimura H, Saltis J. Hormonal regulation of glucose transport in rat adipose cells. Biochem Soc Trans 18:1123-1125, 1990
11. Kakehi T, Kuzuya H, Kosaki A, Yamada K, Yoshimasa Y, Okamoto M, Nishimura H, Nishitani H, Saida K, Kuno S, Imura H. Binding activity and autophosphorylation of the insulin receptor from patients with myotonic dystrophy. J Lab Clin Med 115: 688-695, 1990
12. Okamoto M, Okamoto M, Nishimura H, Kosaki A, Kono S, Inoue G, Maeda I, Kubota M, Hayashi T, Kuzuya H, Imura H. Insulin-stimulated glucose uptake and fasting blood glucose. Endocrinol Jpn 38(4): 421-427, 199113.Nishimura H, Saltis J, Habberfield AD, Garty NB, Greenberg AS, Cushman SW, Londos C, Simpson IA. Phosphorylation state of the GLUT4 isoform of the glucose transporter in subfractions of the rat adipose cell: effects of insulin, adenosine, and isoproterenol. Proc Natl Acad Sci USA 88: 11500-11504, 1991
14. Kosaki A, Kuzuya H, Nishimura H, Inoue G, Okamoto M, Kakehi T, Okamoto M, Kono S, Maeda I, Kubota M, Imura H. Regulation of glucose transporter synthesis in cultured human skin fibroblasts. Mol Cell Endocrinol 75: 189-196, 1991
15. Vannucci SJ, Nishimura H, Satoh S, Cushman SW, Holman GD, Simpson IA. Cell surface accessibility of GLUT4 glucose transporters in insulin-stimulated rat adipose cells. Modulation by isoprenaline and adenosine. Biochem J 288: 325-330, 199216. Nishimura H, Kuzuya H, Kosaki A, Okamoto M, Okamoto M, Kono S, Inoue G, Maeda I, Imura H. Monoclonal antibodies possibly recognize conformational changes in the human erythrocyte glucose transporter. Biochem J 281: 103-106, 1992
17.Nishimura H, Zarnowski MJ, Simpson IA. Glucose transporter recycling in rat adipose cells. Effects of potassium depletion. J Biol Chem 268: 19246-19253, 199318. Satoh S, Nishimura H, Clark AE, Kozka IJ, Vannucci SJ, Simpson IA, Quon MJ, Cushman SW, Holman GD. Use of bismannose photolabel to elucidate insulin-regulated GLUT4 subcellular trafficking kinetics in rat adipose cells. Evidence that exocytosis is a critical site of hormone action. J Biol Chem 268(24): 17820-17829, 1993
19.Nishimura H, Pallardo FV, Seidner GA, Vannucci S, Simpson IA, Birnbaum MJ. Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. J Biol Chem 268(12): 8514-8520, 1993
20. Kono S, Kuzuya H, Yamada K, Yoshimasa Y, Okamoto M, Nishimura H, Kosaki A, Inoue G, Hayashi T, Imura H. Preparation of anti-phosphoserine and anti-phosphothreonine antibodies and their application in the study of insulin- and EGF-induced phosphorylation. Biochem Biophys Res Commun 190: 283-288, 1993
21. Sako Y, Inoue T, Sugawara A, Nishimura H, Koshimura O, Morimoto A, Koishi H. Thyroid function in the aged of 80 years and over, actively living at home. Proceedings of the XVth Congress of the international Association of Gerontology 769-773, 1993
22. Ueda Y, Sugawa H, Akamizu T, Okuda J, Kiho Y, Mori T. ImmunoglobulinG that interferes with thyroid-stimulating antibody measurements can be eliminated specifically by incubation with synthetic peptides corresponding to partial sequences of the human thyrotropin receptor. Thyroid 3:111-117, 1993
23.Nishimura H, Simpson IA. Staurosporine inhibits phorbol 12-myristate-13-acetate- and insulin-stimulated translocation of GLUT1 and GLUT4 glucose transporters in rat adipose cells. Biochem J 302: 271-277, 199424. Kraemer FB, Sather SA, Park B, Sztalryd C, Natu V, May K, Nishimura H, Simpson IA, Cooper AD, Cushman SW. Low density lipoprotein receptors in rat adipose cells: subcellular localization and regulation by insulin. J Lipid Research 35: 1760-1772, 1994
25. Adachi M, Nishimura H, Inoue T, Sako Y. Adult T-cell leukemia with various abnormalities in endocrine and metabolic systems. British J Haematol 87: 853-855, 1994
26.Okuda J, Akamizu T, Sugawa H, Matsuda F, Hua L, Mori T. Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema. Journal of Clinical Endocrinology and Metabolism 79: 1600-1604, 1994
27. Mori T, Akamizu T, Kosugi S, Sugawa H, Inoue D, Okuda J, Ueda Y. Recent progress in TSH receptor studies in with a new concept of "Autoimmune TSH receptor disease". Endocrine Journal 41: 1-11 , 1994
28. Sugawa H, Akamizu T, Kosugi S, Ueda Y, Oota C, Okuda J, Mori T. Presence of heterogeneous thyroid-stimulating antiboddies in sera from indivisual Graves' patients as shown by synthesized thyrotropin receptor peptide application; evidence showing two independent epitopes and a recognition of two epitopic regions by one antibody molecule. European journal of Endocrinology 133: 283-293,1995,29. Li H, Okuda J, Akamizu T, Mori T. A hyperthyrodism patient with Graves disease who was strongly resistant to methimazole; Investigation on possible mechanism of the resistance. Endocrine journal 42: 697-704 , 1995
30. Akamizu T, Ueda Y, Li H, Okuda J, Mori T. Establishment and characterization of antihuman thyrotropin (TSH) receptor -specific CD4+ Tcell line from a patient with Graves' disease; Evidence for mutiple T cell epitopes on the TSH receptor including tranmembrane domain. Thyroid 4; 259-264, 1995
31. Li H., Akamizu T, Okuda J, Sugawa H, Matuda F, Tubata T, Mori T. Isolation of Epstein-Barr-virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator (MACS); Preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease. Biochemical and Biophysical Research Communications 207: 985-993, 1995
32. Ueda Y, Sugawa H, Akamizu T, Okuda J, Kosugi S, Oota, C, Mori T. Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition. European Journal of Endocrinology 132: 62-68, 1995
33.. Sugawa H, Ueda Y, Akamizu T, Kosugi S, Okuda J, Oota, C, Mori T. Stastical analysis of functional region(s) of the TSH receptor. Journal of Endocrinol Investigation 18: 710-717, 1995
34.Nishimura H, Nishino K, Inoue T, Koshimura O, Sako Y. Effects of Insulin and a Phosphodiesterase (PDE) Inhibitor on Microcirculation of the Foot Skin in NIDDM patients. Diabetes 45: 17A, 199635. Mori T, Sugawa H, Akamizu T, Kosugi S, Okuda J. Laboratory test necessary at the first examination of patients with suspected throid disorders. Endocrine Journal 43: 197-204, 1996
36. Akamizu T, Matsuda F, Okuda J, Li H, Kanda H, Watanabe T, Honjo T, Mori T. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. JImmunol 157: 3148-3152, 1996
37. Nishimura H, Shintani M, Yamamoto Y, Suga J, Tanaka T, Takaya K, Yoshimasa Y, Nakao K. Leptin Decreases Protein and mRNA Levels of GLUT4 in Rat Adipocytes. Diabetes 46: 59A,199738.Shintani M, Nishimura H, Yamamoto Y, Suga J, Tanaka T,Hanaoka I, Yoshimasa Y, Nishi S, Nakao K. Differential Regulation of Isoproterenol and Troglitazone on Leptin and GLUT4 in Rat Adipocytes. Diabetes 46: 86A, 1997
39. Azuma N, Nishimura H, Yamamoto Y, Suga J, Shigemoto M, Nishi S, Yoshimasa Y. Significance of the Trp64Arg Mutation of 3-Adrenergic Receptor Gene in Insulin Resistance. Diabetes 46: 168A,1997
40. Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanaoka I, Hiraoka J, Yasuno A, Nishimura H, Yoshimasa Y, Nishi S, Nakao K. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab 82: 2542-2547, 1997
41. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nature Med 3:1029-1033, 1997
42. Matsuoka N, Ogawa Y, Hosoda K, Matsuda J, Masuzaki H, Miyawaki T, Azuma N, Natsui K, Nishimura H, Yoshimasa Y, Nishi S, Thompson DB, Nakao K. Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity. Diabetologia 40: 1204-1210,1997
43. Shigemoto M, Nishi S, Ogawa Y, Isse N, Matsuoka N,Tanaka T, Azuma N, Masuzaki H, Nishimura H, Yoshimasa Y, Hosoda K, NakaoK. Molecular screening of both th epromoter and the protein coding regions in the human ob gene in Japanese obese subjects with non-insulin-dependent diabetes mellitus (NIDDM). Eur J Endocrinol 137: 511-513, 1997
44. Matsuda J, Hosoda K, Itoh H, Son C, Doi K, Tanaka T, Fukunaga Y, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Nakao K. Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet. FEBS Lett 418:200-204, 1997
45. Azuma N, Yoshimasa Y, Nishimura H, Yamamoto Y, Masuzaki H, Suga J, Shigemoto M, Matsuoka N, Tanaka T, Sattoh N, Igaki T, Miyamoto Y, Itoh H, Yoshimasa T, Hosoda K, Nishi S, Nakao K. The significance of the Trp64Arg mutation of the B3-adrenergic receptor gene in impaired glucose tolerance, non-insulin-dependent diabetes mellitus and insulin resistance in Japanese subjects. Metabolism 47: 456-460, 199846. Yonemitsu Y, Shintani M, Yamamoto Y, Matsuoka N, Suga J, Hosoda K, Yoshimasa Y, Nishimura H. Effect of Leptin and Troglitazone on Glucose Uptake in L6 Myotcytes. Diabetes 47: A272, 1998
47.Shintani M, Nishimura H, Yonemits S, Hosoda K, Hiraoka J, Matsuoka N, Yoshimasa Y, Nishi S, Nakao K. Differential Regulation of Free Fatty Acid and Troglitazone on Leptin and GLUT4 in Rat Adipocytes. Diabetes 47: 319A, 1998
48. Matsuda J, Hosoda K, Itoh H, Son C, Doi K, Hanaoka I, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Odaka H, Nakao K. Increased adipose expression of uncoupling protein-3 gene by thizolidinediones in Wister fatty rats and in cultured adipocytes. Diabetes 47:1809-1814, 1998
49. Tanaka,T, Itho H, Doi K, Fukunaga Y, Hosoda K, Shintani M,Yamashita J, Chun T-H, Inoue M, Masatsugu K, Sawada N, Saito T, Inoue G, Nishimura H, Yoshimasa Y , Nakao K. Down regulation of peroxisome proliferator-activated receptorg expressionn by inflammatory cytokinesn and its reversal by thiazolidinediones. Diabetologia 42:702-710, 199950. Shintani M,Nishimura H, Akamizu T, Yonemitsu S, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Thyrotropin decreases leptin production in rat adipocytes. Metabolism 48:1570-1574, 1999
51. Masuzaki H, Ogawa Y, Aizawa-Abe M, Hosoda K, Suga J, Ebihara K, Satoh N, Iwai H, Inoue G, Nishimura H, Yoshimasa Y, Nakao K Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes 48:1615-1622, 1999
52. Ogawa Y, Masuzaki H, Hosoda K, Aizawa-Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N, Odaka H, Kasuga H, Fujisawa Y, Inoue G, Nishimura H, Yoshimasa Y, Nakao K Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 48:1822-1829, 1999
53. Itoh H, Doi K, Tanaka T, Fukunaga Y, Hosoda K, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Nakao K Hypertension and insulin resistance: role of peroxisome proliferator-activated receptor gamma. Clin Exp Pharmacol Physiol 26: 558-560, 1999
54. Tanaka A, Maeda K, Sawai K, Okuda J, Sugawara A, Kuwahara T. Concealed hypothyroidism in patients with myeloperoxidase antineutrophili cytoplasmic autoantibodies-(MPO-ANCA) positive renal disease. Clinical Nephrology 52: 91-95, 1999
55. Shintani M,Nishimura H, Yonemitsu S, Ogawa Y, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. TSH and Leptin. Downregulation of leptin by free fatty acids in rat adipocytes:Effects of triacsin C,palmitate,and 2-bromopalmitate. Metabolism:Clinical & Experimental.,49(3): 326-330 Mar 2000.56. Kan S, Onodera H, Furutani E, Aung T, Araki M, Nishimura H, Maetani S, Imamura M: Novel Control System for Blood Glucose using a Model Predictive Method ASAIO Journal (American Society for Artificial Organs)46:657-662, 2000
57. Yamamoto Y, Yoshimasa Y, Koh M, Suga J, Masuzaki H, Ogawa Y, Hosoda K, Nishimura H, Watanabe Y, Inoue G, Nakao K. Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 andGLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes. 49(3):332-9,2000
58. Cheol Son, Kiminori Hosoda, Junichi Matsuda, Junji Fujikura, Hiroshi Iwakura, Shin yonemitsu, Haruo Nishimura. Upregulation of UCP3 Gene Expression by Fatty Acids Via Peroxisome Proliferator-Activated Receptor ｶ in L6 Myptubes. Diabetes 49(S): 61, 2000
59.Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 2001 Feb;50(2):227-32.200160.Yonemitsu S, Nishimura H, Shintani M, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Hayashi T, Nakao K. Troglitazone induces GLUT4 translocation in L6 Myotcytes. Diabetes 50(5): 1093-1101, 2001
61. Ebihara K, Ogawa Y, Masuzaki H, Shintani M, Miyanaga F, Aizawa-Abe M, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Gavrilova O, Reitman ML, Nakao K. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 50(6):1440-8, 2001
62.